Shire is Appealing Against the National Institute for Health and Clinical Excellence’s Final Appraisal Determination on
FinanzNachrichten - Jun 15 1:06 AM
Shire markets the acetylcholinesterase inhibitor Reminyl(R) and Reminyl XL (galantamine)[2] in the UK. It is licensed for the treatment of mild and moderately severe dementia of the Alzheimer type.Save to My Web
EU lawmakers urge status quo on stem cell research
Reuters via Yahoo! News - Jun 15 7:06 AM
EU scientists should get a much-needed boost of public money over the next seven years even though Europe is likely to retain its cautious approach to stem cell research, EU lawmakers agreed on Thursday.Save to My Web
Randolph man’s goal is Alzheimer’s cure
Daily Record - Jun 15 2:10 AM
RANDOLPH — John O’Marra found himself having more free time as his four children grew up and began heading off to college. He’s been filling much of that time lately with preparations for one of the biggest and most unusual fundraisers in the state — the annual Alzheimer’s Polo Classic.Save to My Web
High Mental Activity Protects Against Alzheimer’s Disease in Mice
KTBS - Jun 12 12:45 PM
TAMPA, Fla. — Researchers at the Byrd Alzheimer’s Research Institute in Tampa, Florida have determined that Alzheimer’s mice placed in a mentally enriched environment outperform similar mice in traditional environments and behaviorally match those not suffering from the disease.Save to My Web
Alzheimer’s vaccine ‘promising’
BBC News - Jun 12 7:47 PM
A potential vaccine for Alzheimer’s disease cuts build up of damaging proteins in mice brains.Save to My Web